Tarek Besheer

593 total citations
35 papers, 405 citations indexed

About

Tarek Besheer is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Tarek Besheer has authored 35 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 25 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Tarek Besheer's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (19 papers) and Hepatitis B Virus Studies (10 papers). Tarek Besheer is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (19 papers) and Hepatitis B Virus Studies (10 papers). Tarek Besheer collaborates with scholars based in Egypt, Saudi Arabia and Vietnam. Tarek Besheer's co-authors include Hatem Elalfy, Mahmoud El‐Bendary, Abdel‐Hady El‐Gilany, Hosam Zaghloul, Gamal Esmat, Wagdi Elkashef, Nasser Mousa, Ahmed Abdel‐Razik, Ahmed Abdel Khalek Abdel Razek and Waleed Eldars and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and Cells.

In The Last Decade

Tarek Besheer

34 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarek Besheer Egypt 13 215 183 76 52 48 35 405
Hatem Elalfy Egypt 14 210 1.0× 189 1.0× 63 0.8× 49 0.9× 58 1.2× 39 383
Premashish Kar India 11 150 0.7× 255 1.4× 73 1.0× 45 0.9× 23 0.5× 32 402
Carmen Monica Preda Romania 12 297 1.4× 231 1.3× 42 0.6× 22 0.4× 37 0.8× 52 445
N. Maàmouri Tunisia 9 164 0.8× 155 0.8× 47 0.6× 29 0.6× 36 0.8× 65 307
Antonios Katsounas Germany 12 192 0.9× 187 1.0× 51 0.7× 43 0.8× 104 2.2× 36 424
Alain Cazier France 10 307 1.4× 323 1.8× 35 0.5× 17 0.3× 33 0.7× 21 544
Zhiliang Gao China 13 311 1.4× 303 1.7× 66 0.9× 104 2.0× 43 0.9× 59 520
Xingfei Pan China 12 124 0.6× 76 0.4× 105 1.4× 75 1.4× 69 1.4× 36 385
Nóra Sipeki Hungary 11 205 1.0× 191 1.0× 38 0.5× 30 0.6× 74 1.5× 22 385
Jason Eccleston United States 6 200 0.9× 152 0.8× 54 0.7× 58 1.1× 58 1.2× 13 359

Countries citing papers authored by Tarek Besheer

Since Specialization
Citations

This map shows the geographic impact of Tarek Besheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Besheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Besheer more than expected).

Fields of papers citing papers by Tarek Besheer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarek Besheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Besheer. The network helps show where Tarek Besheer may publish in the future.

Co-authorship network of co-authors of Tarek Besheer

This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Besheer. A scholar is included among the top collaborators of Tarek Besheer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Besheer. Tarek Besheer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elalfy, Hatem, Tarek Besheer, Abdel‐Hady El‐Gilany, et al.. (2021). Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19. Journal of Medical Virology. 93(5). 3176–3183. 44 indexed citations
2.
Besheer, Tarek, Hatem Elalfy, Ahmed Abdel Khalek Abdel Razek, et al.. (2019). Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus. World Journal of Gastroenterology. 25(11). 1366–1377. 32 indexed citations
3.
El‐Bendary, Mahmoud, Hatem Elalfy, Tarek Besheer, et al.. (2019). Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients. Immunological Investigations. 49(4). 462–476. 27 indexed citations
4.
Besheer, Tarek, Mona F. Arafa, Hatem Elalfy, et al.. (2018). Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. The Turkish Journal of Gastroenterology. 29(3). 299–307. 18 indexed citations
5.
El‐Bendary, Mahmoud, Hatem Elalfy, Tarek Besheer, et al.. (2018). Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. British Journal of Biomedical Science. 76(1). 11–16. 7 indexed citations
6.
Farouk, Omar, Basel Refky, Ziad Emarah, et al.. (2018). Multidetector computed tomography evaluation of synchronous lymphoma and other solid malignancies. Journal of Cancer Research and Therapeutics. 16(1). 60–60. 3 indexed citations
7.
Shalaby, Asem, et al.. (2018). Evaluation of the role of Notch1 expression in hepatic carcinogenesis with clinico-pathological correlation. Pathology. 50(7). 730–736. 3 indexed citations
8.
El‐Bendary, Mahmoud, Hatem Elalfy, Tarek Besheer, et al.. (2018). HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study. Annals of Hepatology. 18(1). 68–77. 13 indexed citations
9.
Elalfy, Hatem, Tarek Besheer, Khaled Farid, et al.. (2018). Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization. British Journal of Biomedical Science. 75(4). 187–191. 18 indexed citations
10.
11.
Besheer, Tarek, Mahmoud El‐Bendary, Hatem Elalfy, et al.. (2017). Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors. Journal of Interferon & Cytokine Research. 37(3). 97–102. 28 indexed citations
12.
Besheer, Tarek, Ahmed Abdel Khalek Abdel Razek, Mahmoud El‐Bendary, et al.. (2017). Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?. The Turkish Journal of Gastroenterology. 28(4). 283–288. 17 indexed citations
13.
Elalfy, Hatem, et al.. (2017). Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer. 49(3). 260–267. 7 indexed citations
14.
Elhadidy, Tamer, et al.. (2017). Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus. SHILAP Revista de lepidopterología. 66(2). 363–367. 3 indexed citations
15.
El‐Bendary, Mahmoud, Gamal Esmat, Hatem Elalfy, et al.. (2016). Associations of human leucocyte antigen class II‐DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family‐based study. Journal of Viral Hepatitis. 23(12). 961–970. 11 indexed citations
16.
El‐Bendary, Mahmoud, Gamal Esmat, Tarek Besheer, et al.. (2014). Epidemiological Aspects of Intrafamilial Spread of HCV Infection in Egyptian Population: A Pilot Study. Open Journal of Gastroenterology. 4(5). 228–236. 13 indexed citations
17.
Palmieri, James R., et al.. (2014). Comparison of microscopic and immunoassay examination in the diagnosis of intestinal protozoa of humans in Mansoura, Egypt. Journal of Parasitic Diseases. 40(3). 580–585. 8 indexed citations
18.
Besheer, Tarek, et al.. (2013). Prevalence and risk factors for spontaneous bacterial pleuritis in cirrhotic patients with hydrothorax. SHILAP Revista de lepidopterología. 62(3). 435–438. 7 indexed citations
19.
Mousa, Nasser, et al.. (2012). Is Combination Therapy Interferon and Ribavirin in Patients with Chronic Hepatitis C Infection Toxic for Eyes?. Journal of Ocular Pharmacology and Therapeutics. 29(3). 345–348. 8 indexed citations
20.
Besheer, Tarek, et al.. (2012). Utility of QuantiFERON-TB Gold In-Tube testing in the detection of latent tuberculosis in liver transplant candidates. Egyptian Liver Journal. 2(3). 67–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hatem Elalfy Breakdown of academic impact, for papers by Premashish Kar Breakdown of academic impact, for papers by Carmen Monica Preda Breakdown of academic impact, for papers by N. Maàmouri Breakdown of academic impact, for papers by Antonios Katsounas Breakdown of academic impact, for papers by Alain Cazier Breakdown of academic impact, for papers by Zhiliang Gao Breakdown of academic impact, for papers by Xingfei Pan Breakdown of academic impact, for papers by Nóra Sipeki Breakdown of academic impact, for papers by Jason Eccleston
Rankless by CCL
2026